• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Challengers of the Status Quo In Physician Payment — Paying Primary Care Physicians More Than Specialists

Publication
Article
MHE PublicationMHE March 2023
Volume 33
Issue 03

This part of the month's cover story series features Suzanne Delbanco, Ph.D., M.P.H., executive director of the Catalyst for Payment Reform, who has the provocative suggestion of flipping physician payment so primary care physicians are paid more, not less, than specialists. “We spend so much more on specialists than we do on primary care. While a specialist can help people who are already ill, primary care doctors can help people from becoming ill,” she says.

Despite all the regulation, entrenched interests and bureaucratic entanglements, healthcare remains one of the more dynamic sectors of the American economy.
The activity spring partly from altruism: a desire to heal and help. There's also an abundance of resources — and not just a little profit seeking — in a sector that accounts for almost one-fifth of the U.S. economy.
Over the next few days, we are featuring some of the challengers to the status quo in U.S. healthcare: companies, people, trends and ideas that are shaking things up and reshaping the contour of how healthcare is paid for and delivered.

Value-based care was supposed to upend U.S. healthcare. Changing incentives and how the massive amounts of money circulating through the system flowed so providers were rewarded more for prevention and good outcomes and less for volume and intensity would be nothing if not disruptive.

Has it played out that way? “It depends on what you mean by disruption,” says Suzanne Delbanco, Ph.D., M.P.H., executive director of the Catalyst for Payment Reform, a nonprofit group founded in 2010 that has large employers such as Walmart and Home Depot as its members. “If the question is, has it disrupted providers and payers, I think the answer is yes. Has it disrupted the outcomes we were hoping for, meaning has it significantly improved quality or saved money? The answer is no.”

Quality measurement alone has become a “massive industry,” continues Delbanco. “The amount of effort to measure performance and outcomes to tie it back to payments has taken on a life of its own and has not necessarily led to better outcomes.”

One reason value-based care has fallen short, in Delbanco’s view, is the consolidation of providers and rising prices: “Payment reform, value-based payment, value-based care — whatever you call it — does not address prices.” And although payment reform may be making providers more efficient, if prices are high, those who use and pay for healthcare are not going to experience the benefits, she says.

If you are looking to truly disrupt healthcare, Delbanco has the provocative suggestion of flipping physician payment so primary care physicians are paid more, not less, than specialists. “We spend so much more on specialists than we do on primary care. While a specialist can help people who are already ill, primary care doctors can help people frombecoming ill,” she says.

Accountable care organizations have been billed as a way to channel more healthcare dollars into primary care, but Delbanco says they leave intact the wide gap in payments between primary care physicians and specialists.Boosting payment to primary care physicians might start to fix American medicine’s turn away from primary care, says Delbanco, who mentions that her father, Tom Delbanco, is a primary care physician and an internist and professor at Harvard Medical School.

“It used to be that the best and the brightest went into primary care because it was the most challenging,” Delbanco says. “I don’t mean because you have to see a patient every five minutes. I mean that every time a patient walks through the door, you don’t know what’s going to come at you, and you have to be prepared for anything.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.